Vanguard Capital Management
PROK icon

Vanguard Capital Management’s ProKidney PROK Stock Holding History

Vanguard Capital Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
1,175,257
+28,320
+2% +$51.8K ﹤0.01% 3357
2026
Q1 		$2.05M Buy
+1,146,937
New +$2.43M ﹤0.01% 3355

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management's PROK Position: Q2 2026 in Review

Vanguard Capital Management increased its ProKidney (PROK) stake by 2.5% in Q2 2026, buying an estimated $51.8K and bringing the position to 1,175,257 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3357.

Vanguard Capital Management first reported a position in PROK in Q1 2026 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Vanguard Capital Management held 1,175,257 shares of ProKidney worth $2.4M as of Q2 2026.
  • Vanguard Capital Management bought 28,320 ProKidney shares in Q2 2026, an estimated $51.8K.
  • ProKidney made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3357 holding.
  • Vanguard Capital Management first reported a position in ProKidney in Q1 2026 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.